Indoleamine 2,3-dioxygenase controls purinergic receptor-mediated ischemia-reperfusion injury in renal tubular epithelial cells
- PMID: 35918786
- DOI: 10.1515/jbcpp-2022-0128
Indoleamine 2,3-dioxygenase controls purinergic receptor-mediated ischemia-reperfusion injury in renal tubular epithelial cells
Abstract
Objectives: Ischemia-reperfusion (I-R) injury is the most common cause of acute kidney injury (AKI). Experimental studies have shown that indoleamine 2,3-dioxygenase 1 (IDO) and the purinergic receptor P2X7 contribute to kidney I-R injury. We evaluated whether there is an interplay between IDO and P2X7 in the pathogenesis of I-R injury.
Methods: Primary renal proximal tubular epithelial cells (RPTECs) were subjected to anoxia or reoxygenation with or without specific inhibitors. Cell imaging, colorimetric assays, and Western blotting were used.
Results: Cell imaging revealed that inhibition of IDO, or all the purinergic receptors with an ATPase, or specific inhibition of P2X7 rescued the cells from anoxia or reoxygenation-induced cell death. This was confirmed with LDH release assay, which also detected the ferroptotic nature of cell death due to reoxygenation. On the contrary, activated cleaved caspase 3 increased during anoxia, showing that apoptosis prevails. All the aforementioned treatments prevented caspase increase. Both anoxia and reoxygenation increased extracellular ATP, IDO, and P2X7 expression. IDO remained unaffected by the above-mentioned treatments. On the contrary, treatment with apyrase or inhibition of P2X7decreased extracellular ATP and P2X7 expression, which are also decreased by inhibition of IDO. The first indicates a positive feedback loop regarding P2X7 activation, expression and function, while the latter implies that IDO controls P2X7 expression.
Conclusions: In RPRECs subjected to anoxia or reoxygenation, IDO is upregulated, increasing P2X7 and contributing to anoxia or reoxygenation-induced cell death. Clarifying the molecular mechanisms implicated in kidney I-R injury is of particular interest since it may lead to new therapeutic strategies against AKI.
Keywords: P2X7; acute kidney injury; indoleamine 2,3-dioxygenase; ischemia-reperfusion injury.
© 2022 Walter de Gruyter GmbH, Berlin/Boston.
References
-
- Neri, M, Riezzo, I, Pascale, N, Pomara, C, Turillazzi, E. Ischemia/reperfusion injury following acute myocardial infarction: a critical issue for clinicians and forensic pathologists. Mediat Inflamm 2017;2017:7018393. https://doi.org/10.1155/2017/7018393 . - DOI
-
- Bakthavachalam, P, Shanmugam, PST. Mitochondrial dysfunction – silent killer in cerebral ischemia. J Neurol Sci 2017;375:417–23. https://doi.org/10.1016/j.jns.2017.02.043 . - DOI
-
- Tsukamoto, T, Chanthaphavong, RS, Pape, HC. Current theories on the pathophysiology of multiple organ failure after trauma. Injury 2010;41:21–6. https://doi.org/10.1016/j.injury.2009.07.010 . - DOI
-
- Ronco, C, Bellomo, R, Kellum, JA. Acute kidney injury. Lancet 2019;394:1949–64. https://doi.org/10.1016/s0140-6736(19)32563-2 . - DOI
-
- Hsu, CY. Yes, AKI truly leads to CKD. J Am Soc Nephrol 2012;23:967–9. https://doi.org/10.1681/ASN.2012030222 . - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials